The i3S recently hosted a guided visit for representatives from Novartis, with the aim of identifying shared scientific interests and fostering future strategic partnerships between the two institutions.

The Novartis delegation included the newly appointed Country Medical Director, the Medical Manager for Neurosciences, a Medical Scientific Liaison, and a Clinical Research Manager Advisor. The visit was organized by the project manager of the ERA Chair and designed to showcase i3S’s strengths in cutting-edge neurobiology research with strong translational potential.
Particular emphasis was placed on ongoing projects considered especially promising in terms of translational value, including presentations from Dr. Ana Paula Pêgo (NanoBiomaterials for Targeted Therapies Group); Dr. Pedro Martins (Biomolecular Structure and Function Group) and Dr. Matthew Holt (NCBio ERA Chair, Synapse Biology Group). The visit also included a guided tour of i3S’s scientific platforms, highlighting the institute’s advanced technological capabilities and interdisciplinary research environment.
This visit marks an important step toward strengthening links between academic research and industry, reinforcing i3S’s commitment to translating fundamental neuroscience discoveries into innovative therapeutic solutions.



